pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Methylphenidate Padagis
drug
save

methylphenidate ER

Marketedupdated 3mo ago
by Padagis LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval466 co-mentions · 233 sources
  • drugMETADATE CD378 co-mentions · 206 sources
  • drugMETADATE ER248 co-mentions · 206 sources
  • drugmethylphenidate238 co-mentions · 238 sources
  • drugRITALIN LA231 co-mentions · 206 sources
  • drugQuillivant XR220 co-mentions · 206 sources
  • drugMETHYLIN ER219 co-mentions · 206 sources
  • drugMethylin219 co-mentions · 206 sources

all catalysts(0)

nothing on the calendar yet

Trials studying methylphenidate ER

  • phase3Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.completedn=26
  • phase4EEG Biomarkers for ADHD Stimulant Treatmentnot yet recruitingn=220
  • —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
  • phase1A Trial to Assess How Centanafadine Interacts With Stimulants in the Bodyrecruitingn=42
  • phase3Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301completedn=103
  • phase3Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHDterminatedn=26
  • phase4A Safety/Tolerability and PK Study With Azstarys® in Children With ADHDcompletedn=123
  • phase3Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301suspendedn=45
more trials →

News(0)

no news has mentioned this drug yet

brand
Methylphenidate Padagis
generic
methylphenidate
indication
Attention Deficit Hyperactivity Disorder (ADHD)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 39m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?